Lexicon Pharmaceuticals, Inc. [LXRX] Price Analysis: Next Bullish Target is $8.00

Lexicon Pharmaceuticals, Inc. [LXRX] is following upward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $4.91 after LXRX shares went up by 0.72% during the last trading session. One of the reasons why Healthcare stocks may go bullish is increased momentum in the press.

Lexicon Pharmaceuticals, Inc. [NASDAQ:LXRX]: Analyst Rating and Earnings

Its stock price has been found in the range of 1.13 to 8.39. This is compared to its latest closing price of $4.87.

Keep an eye out for the next scheduled publication date for this company’s financial results, which are expected to be released on Wed 11 Mar (In 93 Days).

Fundamental Analysis of Lexicon Pharmaceuticals, Inc. [LXRX]

Now let’s turn to look at profitability: with a current Operating Margin for Lexicon Pharmaceuticals, Inc. [LXRX] sitting at -163.39 and its Gross Margin at +93.08, this company’s Net Margin is now 49.90%. These measurements indicate that Lexicon Pharmaceuticals, Inc. [LXRX] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is -40.00, and its Return on Invested Capital has reached -47.20%. Its Return on Equity is -938.23, and its Return on Assets is -33.02. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates LXRX financial performance.

Similarly, its Total Debt to Total Capital is 112.08, while its Total Debt to Total Assets stands at 84.88.